Finally, recent data suggest that cancer biomarkers correlate positively with NT-proBNP plasma levels in patients with heart failure, and even some of them were noninferior to NT-proBNP in predicting all-cause mortality [31]. This evidence concerns the gene NPPB and heart failure.